Top Banner

of 6

TB Alliance's presentation at World TB Day 2016 webinar

Jul 07, 2018

Download

Documents

bobbyramakant
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
  • 8/19/2019 TB Alliance's presentation at World TB Day 2016 webinar

    1/12

    Progress in

    Uptake ofPediatricMedicines

    Shelly Malhotra and Joanna Breitstein

    TB Alliance

  • 8/19/2019 TB Alliance's presentation at World TB Day 2016 webinar

    2/12

    2

    1 million children develop TB each year. 53million carry the TB infection, but don’t show

    symptoms (yet).

    • 140,000 children die each year of a disease that

    can be prevented & treated.

    • Child health and survival is improving, with

    fewer deaths from diseases such as malaria and

    pneumonia. But TB lingers, and lacks

    attention/resources to the problem.

    Childhood TB: Hiding in the shadows

  • 8/19/2019 TB Alliance's presentation at World TB Day 2016 webinar

    3/12

    3

    • In 2010, WHO changed their dosingrecommendations for children with TB,

    but manufacturers were unresponsive

    • With no appropriately-dosed, child-

    friendly TB medicines, providers had to

    cut, crush, or combine tablets toachieve desired dose

    • Poor tasting medicines made

    administration challenging and caused

    vomiting, decreasing adherence

    • Inconsistent administration fromcountry to country has meant there is

    no unified response to the problem

    Lack of consideration of the unique needs of children

    Sub-optimal treatment for children

  • 8/19/2019 TB Alliance's presentation at World TB Day 2016 webinar

    4/12

    4

    • With investment from UNITAID and others,

    and together with WHO and partners, TB

    Alliance has announced availability of child-

    friendly medicines in the correct doses

    o Rifampicin 75 mg + Isoniazid 50 mg +

    Pyrazinamide 150 mgo Rifampicin 75 mg + Isoniazid 50 mg

    • Available through the Global Drug Facility

    (GDF) and directly through the manufacturer

    (Macleods)

    •WHO Prequalification anticipated in mid 2016

    • The average treatment cost is $15.54

    Simple to use, affordable, and appropriately dosed

    Child-Friendly FDCs Now Available

  • 8/19/2019 TB Alliance's presentation at World TB Day 2016 webinar

    5/12

    5

    Improving treatment for children

  • 8/19/2019 TB Alliance's presentation at World TB Day 2016 webinar

    6/12

    6

    • Registration: – Filings underway, with accelerated pathways being sought in some countries

     – Registration secured in India and Cote d’Ivoire already

    • Policy: –

    Policy guidelines adopted in 19 of 22 high burden countries• Funding:

     – Countries have proactively budgeted for pediatric procurement

     – Gaps possible in supporting costs related to product transition

    • Procurement: – Underway with 30,000,000 tablets ordered to date – Technical support being provided to facilitate phasing out of old treatment and

    phasing in of new treatments

    Progress in Introducing New Child-Friendly FDCs

    From Availability to Uptake

  • 8/19/2019 TB Alliance's presentation at World TB Day 2016 webinar

    7/127

    EVERY CHILD

    HAS ACCESSTO THE NEWPRODUCT

    ADVOCATES/CIVIL SOCIETY

    - Encourage government to

    register and adopt new products

    - Advocate for scale up ofeffective childhood TB

    interventions

    COMMUNITY/PROVIDERS

    - Integrate questions about TB into child healthscreening

    - Ask about availability of child-friendlytreatments

    - Scale up contact-tracing

    GOVERNMENTS/HEALTH PROGRAMS

    - Include Child TB in strategies and budgets

    - Fast-track product registration

    - Implement current guidelines

    - Develop plans for phasing in improved

    treatments

    - Scale-up effective childhood TB interventions

    DONORS

    - Fund new treatments andintroduction related costs

    - Support technical assistance tofacilitate transition

    Everyone can play a role

    Adoption-ready: Speeding access to new products

  • 8/19/2019 TB Alliance's presentation at World TB Day 2016 webinar

    8/128

    There’s still work to be done

    It’s time to get

    Louder Than TB!

  • 8/19/2019 TB Alliance's presentation at World TB Day 2016 webinar

    9/129

    Louder Than TB Campaign

    Global leaders are joining forces with leaders from the private &public sectors and media to:

    • Raise awareness of childhood TB as a critical issue on the

    maternal and child health and survival agenda and as partof the Global Goals;

    • Promote the need for integration of TB into other

    maternal and childhood services at the country level to

    find children with TB and treat them with the best

    solutions available;

    • Ensure the most vulnerable have access to TB prevention;

    • Drive further investment in innovation of new TB drugs,

    diagnostic tools, and vaccines

  • 8/19/2019 TB Alliance's presentation at World TB Day 2016 webinar

    10/12

    10Introduction of Child-Friendly TB Medicines

    Come Join Us on World TB Day & Beyond

  • 8/19/2019 TB Alliance's presentation at World TB Day 2016 webinar

    11/12

    11

    Come Join Us on World TB Day & Beyond

  • 8/19/2019 TB Alliance's presentation at World TB Day 2016 webinar

    12/12

    12

    Here’s how you can raise your voice

    Visit LouderThanTB.org to learn more!•Join our Coalition of Partners!

    •Post, share, follow the Campaign to raise the volume around

    childhood TB on World TB Day, March 24th

    •Stay tuned for future initiatives!